2009
DOI: 10.1016/j.jneumeth.2009.02.021
|View full text |Cite
|
Sign up to set email alerts
|

Improving the recovery of S100B protein in cerebral microdialysis: Implications for multimodal monitoring in neurocritical care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 34 publications
0
6
0
1
Order By: Relevance
“…These studies have focused on a general description of the proteome or selective study of unique proteins as predictive biomarkers. A variety of cytoskeletal and neuronal proteins such as S100B, neuron-specific enolase (NSE), myelin-basic protein (MBP), and glial fibrillary acidic protein (GFAP) have been detected in these studies [1315]. Interpretation of proteomic studies on serum is challenging since the proteins or proteolytic fragments from the damaged brain tissue are reabsorbed via the arachnoid villie into the blood [7] and this may lead to additional dilution effects.…”
Section: Discussionmentioning
confidence: 99%
“…These studies have focused on a general description of the proteome or selective study of unique proteins as predictive biomarkers. A variety of cytoskeletal and neuronal proteins such as S100B, neuron-specific enolase (NSE), myelin-basic protein (MBP), and glial fibrillary acidic protein (GFAP) have been detected in these studies [1315]. Interpretation of proteomic studies on serum is challenging since the proteins or proteolytic fragments from the damaged brain tissue are reabsorbed via the arachnoid villie into the blood [7] and this may lead to additional dilution effects.…”
Section: Discussionmentioning
confidence: 99%
“…Only samples collected after this equilibration period were investigated. At the end of each 1 h collection period, the microdialysate of the extracellular fluid was immediately analysed for lactate and pyruvate with the bedside CMA 600 Analyser (CMA Microdialysis) using an enzymatic colourimetric technique ( Afinowi et al ., 2009 ). For quality control analysis, artificial CSF samples were analysed on a calibrated YSI 2003 STAT Plus Glucose and Lactate Analyser (YSI Inc., Yellow Springs, Ohio, USA) and compared with the values derived by the CMA 600 Analyser.…”
Section: Methodsmentioning
confidence: 99%
“…Recovery experiments were carried out as previously described ( Afinowi et al ., 2009 ). Large volume (100 ml) CSF samples ( n = 12) were used as source solutions.…”
Section: Methodsmentioning
confidence: 99%
“…It consists of a thin semi permeable catheter, mimicking a blood vessel, which is inserted in the tissue. The catheter is infused with physiological saline (the perfusate) by a mechanical pump and by diffusion, down a concentration gradient, and collects the substances that pass through the catheter membrane [34][35][36].…”
Section: Microdialysismentioning
confidence: 99%